PAMELA THOMAS: Open Payments
NPI 1982445953 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 58 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $329 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $262 |
| ABBVIE INC. | 10 | $159 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Lilly USA, LLC | 8 | $101 |
| Eisai Inc. | 3 | $87 |
| PFIZER INC. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
| Novo Nordisk Inc | 3 | $61 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
Products named: AIRSUPRA, GIMOTI, Leqembi, VRAYLAR, Kerendia, MOUNJARO, UBRELVY, PREVNAR 20.
Industry payments across AZ — which companies pay providers there.
